Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Large-scale neuronal network dysfunction in multiple sclerosis?: Evidence from resting-state fMRI.
Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit.
Correlation of cognitive impairment and thalamic atrophy in MS: For men only?
[Biomarkers in neuromyelitis optica].
CCSVI is associated with multiple sclerosis.
Personality characteristics in MS patients: The role of avoidant personality.
Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.
Fingolimod Phosphate Attenuates Oligomeric Amyloid β-Induced Neurotoxicity via Increased Brain-Derived Neurotrophic Factor Expression in Neurons.
Soluble axoplasm enriched from injured CNS axons reveals the early modulation of the actin cytoskeleton.
Multiple sclerosis and the spinal cord.
Home-Based Balance Training Using the Wii Balance Board: A Randomized, Crossover Pilot Study in Multiple Sclerosis.
Excitotoxic mechanisms of ischemic injury in myelinated white matter.
Mitochondrial changes within axons in multiple sclerosis: an update.
Expression of Ccl11 Associates with Immune Response Modulation and Protection against Neuroinflammation in Rats.
Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles.
Opexa Amends Agreement with Merck Serono and Receives Additional $3 Million Payment to Support Ongoing Development of Tcelna® for Multiple Sclerosis
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
[Magnetic reasonance spectroscopy-guided stereotactic biopsy for brain lesion].
Therapeutic Armamentarium and Health System Coverage of Multiple Sclerosis in Latin America.
Teaching NeuroImages: MRI time lag with acute disseminated encephalomyelitis.
Influence of yoga and aerobics exercise on fatigue, pain and psychosocial status in patients with multiple sclerosis: A Randomized Trial.
Clinical application of susceptibility weighted imaging: exploring from routine service.
Pages
« first
‹ previous
…
195
196
197
198
199
200
201
202
203
…
next ›
last »